[MRI of the pulmonary parenchyma: Towards clinical applicability?]

Rev Pneumol Clin. 2017 Feb;73(1):40-49. doi: 10.1016/j.pneumo.2016.12.008. Epub 2017 Jan 31.
[Article in French]

Abstract

Lung parenchyma has long been considered out of the scope of magnetic resonance imaging (MRI) clinical applicability. However, technological advances have emerged to soluce the technical difficulties and thus, applications in clinical practice have become realistic. Nevertheless, various approaches have been proposed and there is a need to synthetize the most recent literature data in order to envision a rationale to build lung MR protocols for clinical use. In addition, these technological innovations may modify the usual paradigms of lung MRI, which are still not consensual. Thus, lung MR protocols appear to be heterogeneous across expert centers in the current context. In this literature review, we ought to describe a rationale on the need to get an alternative to ionizing imaging modalities, in particular in the follow-up of patients with chronic lung diseases. We will describe the most recent technical advances regarding both morphological and functional MRI. Finally, we will conclude on the clinical applicability of MRI of the pulmonary parenchyma, as a routine or research tool.

Keywords: Asthma; BPCO; COPD; CT; Cystic fibrosis; Fibrose; IRM; Interstitial pulmonary disease; MRI; Mucoviscidose; TDM.

Publication types

  • Review

MeSH terms

  • Contrast Media / therapeutic use
  • Cystic Fibrosis / diagnosis
  • Cystic Fibrosis / pathology
  • Humans
  • Lung / diagnostic imaging*
  • Lung / pathology
  • Magnetic Resonance Imaging* / methods
  • Magnetic Resonance Imaging* / statistics & numerical data
  • Magnetic Resonance Imaging* / trends
  • Parenchymal Tissue / diagnostic imaging*
  • Parenchymal Tissue / pathology

Substances

  • Contrast Media